Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore practical strategies to cut grocery costs without relying on coupons. Save money while still enjoying your favorite foods.
24,365 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Lucid is trading at a level that sparks debate: is this a true bargain or a value trap? This guide breaks down how to...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
Classrooms face a sharp debate as AI tools spread. Educators warn that students can’t reason, while families recalibr...
The spotlight isn’t only on SCHD. Schwab’s international dividend ETF SCHY is quietly stealing the show for investors...
FuelCell Energy stock just dropped after a mixed Q1 2026 report. In this analysis, we break down the what, why, and w...
Tokyo signals dispatching ships to the Middle East would face steep political and legal barriers, as Tokyo weighs all...
Young couples are grappling with recurring requests from in-laws who take vacations, risking long-term savings. Exper...
Remitly’s 2026 earnings outlook hinges on user growth, cross-border volumes, and unit economics. This guide breaks do...
A clear, investor-friendly look at HireQuest's Q1 2026 performance and what the numbers signal for HQI's earnings tra...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...
Small-cap stocks have shown strength this year, but Wells Fargo argues the rally masks deteriorating earnings trends ...